In these two case studies, Eurofins (MO, USA) shares details of how they have used flow cytometry as a bioanalytical tool in clinical sample receptor occupancy assays and regulated environments.
Browsing: flow cytometry
Adding value to cytokine release assays by combining analytical techniques and enhanced data analysis
In this poster, Eurofins (MO, USA) discuss combining analytical techniques and enhancing data analysis to add value to cytokine release assays.
Complete our short survey on flow cytometry and be the first to receive our informative infographic collated from the survey results.
Find out more about the role of exosomes in flow cytometry studies and future pharmacological developments in this interview with Joyce Slusser (KCAS; KS, USA).
Find out more about current challenges and recent developments in seen in the field of flow cytometry in this interview with Clara Brando and Ted Baginski (Eurofins; MO, USA).
In this interview, Rafiq Islam (Celerion) discusses the impact FDA guidance for industry on bioanalytical method validation has had on biomarker research in recent years and shares his thoughts on technologies that will change biomarker research in the future.
In this interview, David Lanham (Eurofins) discusses his work using flow cytometry in early clinical stage work and the progress that has been made to regulate and standardize the field.
In this article, details of the tailored solutions KCAS (KS, USA) offers for flow cytometry are discussed including 13 prequalified biomarker immune monitoring panels for support of clinical trials.
Tumor microenvironment monitoring: isolation and flow cytometric immunophenotyping of exosomes from human plasma
In this poster, KCAS (KS, USA) discuss isolation and flow cytometric immunophenotyping of exosomes from human plasma.
This article from Bioanalysis is focused on the challenges in the development of flow cytometry bioanalytical methods to quantitatively measure CAR-T cell levels in adoptive cell therapy.